Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • Nepal protests
  • Nepal Protests Live
  • Vice-presidential elections
  • iPhone 17
  • IND vs PAK cricket
  • Israel-Hamas war
fp-logo
Ranbaxy to sell Daiichi's anti-hypertension drug in Romania
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Fwire
  • Ranbaxy to sell Daiichi's anti-hypertension drug in Romania

Ranbaxy to sell Daiichi's anti-hypertension drug in Romania

FP Archives • December 20, 2014, 07:53:43 IST
Whatsapp Facebook Twitter

Sevikar, a product from the stable of Daiichi Sankyo, will be available in three different strengths in Romania.

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Ranbaxy to sell Daiichi's anti-hypertension drug in Romania

New Delhi: Drug firm Ranbaxy Laboratories and its parent Daiichi Sankyo today said they will launch Sevikar, a hypertension drug, in Romania under their collaborative business strategy.

Terapia Ranbaxy, a subsidiary of Ranbaxy in Romania, will launch Sevikar, a fixed dose combination of olmesartan medoxomil and amlodipine besylate tablets, Daiichi Sankyo and Ranbaxy Laboratories said in a joint statement.

“.. Leveraging synergies with Daiichi Sankyo is part of our business strategy and this will be our third product introduction as part of the hybrid business model,” Ranbaxy Managing Director and CEO Arun Sawhney said.

STORY CONTINUES BELOW THIS AD

[caption id=“attachment_280938” align=“alignleft” width=“380” caption=“Agencies”] ![](https://images.firstpost.com/wp-content/uploads/2012/04/ranbaxydrug.jpg "ranbaxydrug") [/caption]

Sevikar, a product from the stable of Daiichi Sankyo, will be available in three different strengths in Romania.

The product is expected to be included on the national lists of compensated drugs benefiting patients as it will be made available at an affordable price, the statement added.

More from Fwire
BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents Eight Russian judokas barred from world championships after Ukraine boycott Eight Russian judokas barred from world championships after Ukraine boycott

According to the company, the pharmaceutical market in Romania is valued at about USD 3.3 billion, with the cardiovascular segment being a major contributor with sales of USD 271 million in 2011.

In 2009, Terapia Ranbaxy launched Daiichi’s first product an osteoporosis medication, in the Romanian market followed by the launch of anti bacterial drug in 2010.

Under the hybrid business model, Daiichi Sankyo and Ranbaxy had agreed to exploit synergies in operations to enhance their generic as well as branded business across the globe.

The two companies had entered into an arrangement under which Ranbaxy would market branded products from Daiichi’s portfolio in markets where the Japanese firm does not have a presence.

Daiichi had acquired majority stake Ranbaxy in 2008 for Rs 22,000 crore.

Shares of Ranbaxy Laboratories were trading at Rs 517 on the BSE in late afternnon trade, up 1.67 per cent from its previous close.

STORY CONTINUES BELOW THIS AD

PTI

Tags
NewsTracker Health/Medical/Pharmaceuticals Daiichi Sankyo Terapia Ranbaxy
End of Article
Written by FP Archives

see more

Latest News
Find us on YouTube
Subscribe
End of Article

Top Stories

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV